View
216
Download
0
Embed Size (px)
Citation preview
Podocyte and food antigens in membranous nephropathy
Pierre RoncoINSERM Unit 702
and Division of Nephrology,Tenon hospital, Paris, France
ECP, Helsinki, 2011August 30th
Membranous Nephropathy
Major cause of nephrotic syndrome and chronic renal failure
Aetiologies of membranous nephropathy
• 30% associated with :- infections- cancers- autoimmune diseases- drugs
• 70% « idiopathic forms »
Proteinuria is complement-dependent, and mayinvolve production of oxygen free radicals andmetalloproteases
•
Membranous Nephropathy: IgG Subclass Distribution
IgG1 IgG2 IgG3 IgG4
Idiopathic + + ± ++++
Lupus +++ +++ ++ ±
Neoplasia +++ +++ + +
Ohtani et al, Nephrol Dial Transplant, 2004, 19:574
Possible mechanisms of the formation of subepithelial deposits
Glassock , New Engl J Med 2009, 361:81
Serum Sickness Heymann nephritis « Planted » antigen
Heymann nephritis
Renal BB IgG deposits Megalin, the target antigen of HN
In situ formation of immune deposits
Y YY
Y
YYY
Podocytes
Endothelium
YY
Rat: megalin
Human?
YGBM
Proteinuria
Activation ofcomplement
Kerjaschki and Farquhar
From rats to men : Allo-immune neonatal MN
1982-2002
The case : Hugo D. (male gender)
• 34 Wks of gestation : oligohydramnios and enlarged kidneys• 38 Wks : birth• 1st Days of life : respiratory distress and oligoanuria, followed by nephrotic range proteinuria and increased blood pressure• 4 Wks : CT-guided kidney biopsy• Negative tests for syphilis, toxoplasmosis, cytomegalovirusand hepatitis -B virus infections• Negative Coombs’ test. Normal levels of complement components at day 35
IgG
Infant born with MN and nephrotic syndrome
PLACENTA
C5b-9
MOTHER FETUS
Debiec et al. N Engl J Med 2002, 346:2053
NEP
NEP
NEP
NEP
anti-NEP IgG
before after
Blot: anti-NEP mAb
mother control1 2
83
175
1 2
Potential mechanisms of albuminuria
green - IgG
red - NEP
Profile 9
0.00
50.00
100.00
150.00
200.00
250.00
300.00
0
1.02
2.03
3.05 4.0
7
5.08 6.1
7.12 8.1
3
9.15
10.17
11.18 12
.2
13.22
14.23
15.25
16.27
17.28 18
.3
XY-Position [µm]
Inten
sity
Channel 1
Channel 2
Channel 3
Length [µm]: Sum: Mean: Std. dev.: Minimum: Maximum:
18.64 2685 48.82 43.99 4.00 180.00
18.64 2780 50.55 47.20 0.00 186.00
18.64 3570 64.91 77.64 0.00 255.00
Green IgG
Red NEP
Blue C5b-9
Human IgG NEP
NEWBORN RABBIT KIDNEY
Induction of neonatal renal disease in pregnant rabbit by injection of human
maternal IgG
Why did the mother become immunized without developing the renal disease ?
IgG
(Debiec et al. Lancet. 2004)
NEP deficient
anti-NEP IgG
Genetic defect
M C
PLACENTA
MOTHER
NEP
NEP
NEPC5b-9IgG
Endothelium
GBM
YY
Y Y YYY
Y
Podocytes
FETUS
Infant born with MN and nephrotic syndrome
Feto-Maternal Allo-Immunization with antenatal Glomerulopathies (FMAIG)
Western blotting of glomerular proteins with serum from patients with iMN
Beck et al, New Engl J Med, 2009, 361:11
Expression of PLA2R in normal kidney and glomeruli
Beck et al, New Engl J Med, 2009, 361:11
GWAS analysis of patients with idiopathic MN
• Three cohorts
• Controls : ethnically matched• Illumina platform : 300,000 SNPs• Bioinformatics analysis
Patients Controls
French 75 157
Dutch 146 1,832
British 335 349
Total 556 2,338
Stanescu et al, New Engl J Med, 2011, 364: 616
Single Nucleotide Polymorphisms (SNPs)
• Single base mutation in DNA• Most simple form of genetic polymorphism• 90% of all human DNA polymorphisms• Occur 0.5-10 per every 1 000 base pairs• Not uniformly distributed• > 1, 000, 000 SNPs identified• SNP in a coding region can be
– Synonymous (silent mutation)– Non-synonymous (missense or nonsense mutation)
Principle of pangenomic (GWAS) studies
A risk HLA-DQA1 allele is associated with iMN and may interact with PLA2R alleles
French (n=75 ; c=157) Dutch (n=146 ; c=1832)
British (n=335 ; c=349) All patients (n=556; c=2338)
Stanescu et al, New Engl J Med, 2011, 364: 616
Conclusions
• An HLA-DQA1 allele on chromosome 6p21 is most closely associated with idiopathic membranous nephropathy in persons of white ancestry
• This allele may facilitate an autoimmune response against targets such as variants of PLA2R1
• Our findings suggest a basis for understanding this disease and illuminate how adaptive immunity is regulated by HLA
• The risk of iMN is higher with the HLA-DQA1 allele than with the PLA2R1 allele, suggesting that the HLA-DQ1 allele might favor autoantibody targeting also other antigens
PLA2R autoantibodies and PLA2R glomerular deposits in membranous
nephropathy
Debiec and Ronco, New Engl J Med, 2011, 364 :689
Are there other antigens on the
horizon in patients with idiopathic MN ?
Screening of MN sera reactivity with podocyte « proteome »
Human podocyte lysates
Western blot
analysis
1 2 3 4 5 6 7 8 9
11080
4732
24
Different autoantibody profiles
Patients’ sera
kDa
Identification of antigens
Human podocyte lysate
Differential extraction
Ion exchange chromatography
Silver stainingWestern immunoblottingwith patient’s serum
2D-electrophoresis
Identification
MALDI-TOF MS
MALDI-TOF MS
LC-MS/MS
Candidate autoantigens recognized by autoantibodies in sera from MN patients
« Metabolic » proteins
Cytoskeletal proteinsMolecular chaperones
> 10 Cytoplasm/cytoskeletalproteins
J Am Soc Nephrol 21 : 507-519, 2010
Mechanisms of immune complex formation and podocyte injury in MN
Y
Y
YY
YYY
Y
Activation ofcomplementGBM
Podocytes
C5b-9 C5b-9
ROSProteases
Proteinuria
Cytoskeletalchanges
degradation Detachment
DNAdamage
Apoptosis
Lack ofproliferation
Podocytopenia
EndotheliumYY
Initiation Progression
Stress proteins
Altered intracellular
transport
PLA2R
Renal failure
Enolase (Wakui et al, 1999)
Cytoskeletal proteins
NEPProgression
SOD2Aldose reductase
A role for nonnative antigens?
Glassock , New Engl J Med 2009, 361:81
Serum Sickness Heymann nephritis « Planted » antigen
Anti-BSA antibodies in patients with MN
Debiec et al, NEJM 2011, 364 : 2101
IgG binding of BSA synthetic peptides
CDEFKADEKKFWGKYLY
CTAFHDNEETFLKKYLY
BSA
HSA
A BMNM
BSA HSA
PeptidePeptide
MN patients Controls
Debiec et al, NEJM 2011, 364 : 2101
Debiec et al, NEJM 2011, 364 : 2101
ELISA BSA
B
2D electrophoresis and immunoblot
Circulating BSA in patients with MN
Colocalization of BSA and IgG in immune deposits
BSA IgG
Green BSA
Red IgG
IgG1 IgG2
IgG3 IgG4
1 4 1 4
1 41 41 4 1 4
BSA
BSA
HSA
Biopsy specimen stained for IgG subclasses
Reactivity of eluted IgG
Patient with BSA in biopsy
Patients without BSA in biopsy
Debiec et al, NEJM 2011, 364 : 2101
Y
APC
B cell
YYY
Y YYY Y
Anti-BSAAntibodies
Y YYY
Processing
Digestion
BSA
T cell
Absorption of antigen from the intestinal
tract
Role of BSA in the pathophysiology of MN
2004 2006 2008
5
10
Pro
tein
uri
a g
/l
IgG subclass
2004
2006
2008
initial disease
relapse
remission
1 2 3 4
Circulating BSA1000
500
2004 2006
ng
/ml
2008
Association with disease activity
2005
What do these results teach us?
• The repertoire of antigens involved in « idiopathic » MN may include nonglomerular antigens
• Food cationized BSA and/or abnormal processing of BSA in the GI tract in young children may lead to passage in the blood of cationic BSA, immunization, and in situ formation of immune complexes (Border et al, J Clin Invest, 1982, 69:451)
• These cases point to a role for environmental factors in the pathogenesis of MN
The spectrum of human membranous nephropathies
• Neonatal, alloimmune : NEP• Early childhood MN : BSA
• « Idiopathic » MN- 70-80% : PLA2R (+ other specificities:AR, SOD2, enolase..?)
- 20-30% : other Ags including food/environmental Ag (BSA)
• « Secondary » MNAgs to be identified
• Graft MN- Recurrent : PLA2R (and other antigens)
- de novo : allo-immune
Acknowledgments
TENON CENTER O
F NEPHROLO
GY
Bergamo (I)G. RemuzziM. AbbateNijmegen (NL)J. WetzelsJ. HofstraUKR. Kleta (London)P. Mathieson (Bristol)A.Rees (Vienna)CNG (Evry)D. Bacq-Daian
PaediatriciansV. Guigonis (Limoges, F)A. Bensman (Paris, F)G. Deschênes (Paris, F)T. Ulinski (Paris, F)J. Nauta (Rotterdam, NL)F. Janssen (Brussels, B)J. Nortier (Brussels, B)D. Bockenhauer (London, UK)M. Kemper (Hamburg, D)
B. Stengel (Paris, F)
iMN LN-MN CancerHBV GvH DC HC
N=46664.5%
Europe + AsiaP
osit
ive f
or
an
ti-P
LA
2R
(%
)
100
75
50
25
N=454.4%
N=1428%
N=1817%
N=1315%
N=900%
N=1530%
Secondary MN
Anti-PLA2R antibody in membranous nephropathy
Debiec ,Tesar and Ronco; Hoxha et al, NDT 2011; Qin et al, JASN 2011
100
50
75
25
iMNItaly
N=1643%
iMNJapan
N=14265%
iMNDutch
iMNFrance
N=4257%
N=6080%
iMNChina
iMNGermany
N=10052%
N=8172%
iMNCzech
IFA
N=2568%
Posit
ive f
or
an
ti-P
LA
2R
(%
)
Anti-PLA2R antibody in idiopathic membranous nephropathy
Debiec ,Tesar and Ronco; Hoxha et al, NDT 2011; Qin et al, JASN 2011